Get the injection site ready Choose an injection site (place on your body to give the injection) where you can pinch a 1 to 2-inch (2.5 to 5-centimeter) fold of skin
Phase 3 figures point to a 23.7% mean weight loss at its highest dose over 68 weeks, with some trial participants experiencing as much as 28.7% reduction
Studies also suggest effects on angiogenesis, growth hormone receptor expression, and nitric oxide pathways
Follow-up testing ensures adequate treatment without overcorrection
The free peptide was first identified in human plasma in 1973, and the copper-bound form was recognized shortly afterward as the biologically relevant species in most contexts where the tripeptide has been characterized
In some embodiments, the otic formulation or composition comprises between about 1% to about 7% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof